What does Standard Chem & Pharm Co. Ltd. do?

Standard Chem & Pharm Co. Ltd. (1720.TW) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is 1720.TW's market cap?

Standard Chem & Pharm Co. Ltd. (1720.TW) has a market capitalization of approximately $11.22 billion, as of August 26, 2026, based on the most recent share price and shares outstanding.

Does 1720.TW pay a dividend?

Yes — Standard Chem & Pharm Co. Ltd. (1720.TW) pays a dividend annually, with a trailing-twelve-month yield of 3.50%. Full distribution history, payout ratios, and growth rates are on the Dividend tab.

1720.TW

Standard Chem & Pharm Co. Ltd.

TAI·Drug Manufacturers, Specialty & Generic · Healthcare

NT$57.10NT$0.10−0.17%

Market capNT$11.22B·Market closed·Aug 26 5:30 AM UTC

Price Chart

NT$57.10−NT$0.10 (−0.17%)today

+67.25%CAGR +10.84%

Select date range

FromTo

Jul 23, 2001Aug 26, 2021 → Aug 26, 2026· 5.0 yrsAug 26, 2026

Key Metrics

DividendDividend Tab

Dividend Yield (FWD)3.50%

Annual Dividend (FWD)NT$2.00

Dividend Growth (5Y)+4.1%

Dividend Safety—

Payout Ratio38.6%

FCF Payout Ratio59.2%

Most Recent DividendNT$2.00

Ex-Dividend DateJul 23

Payment DateAug 27

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)+19.3%

EPS Growth (3Y)−3.6%

EPS Growth (5Y)+8.1%

Next Earnings DateAug 12

Last Report DateAug 12

Reported vs EstimateNT$1.18

Earnings Surprise—

FinancialsFinancials Tab

RevenueNT$7.08B

Net IncomeNT$1.03B

Net Margin14.5%

Operating Cash FlowNT$1.58B

Capital ExpendituresNT$456.69M

Free Cash FlowNT$1.12B

Return on Equity16.6%

Return on Invested Capital3.2%

Net CashNT$1.29B

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for 1720.TW and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how 1720.TW's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for 1720.TW and 80,000+ other tickers.

About Standard Chem & Pharm Co. Ltd.

Standard Chem & Pharm Co. Ltd. (SCP) is a Taiwanese enterprise specializing in the development, manufacturing, and commercialization of a broad spectrum of pharmaceutical products, nutritional supplements, and Active Pharmaceutical Ingredients (APIs). The company's diverse offerings include medications targeting various therapeutic areas, such as the circulatory, digestive, and respiratory systems. Their portfolio also features antihistamines, central nervous system (CNS) agents, metabolism-regulating drugs, anti-microbial treatments, and topical preparations for skin and mucous membrane…

CEO: Tzu-Ting Fan
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Exchange: TAI
Employees: 1,130
Website: www.standard.com.tw

Peers

Latest News

News Tab

No recent news available.

Frequently Asked Questions About 1720.TW

What does Standard Chem & Pharm Co. Ltd. do?: Standard Chem & Pharm Co. Ltd. (1720.TW) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is 1720.TW's market cap?: Standard Chem & Pharm Co. Ltd. (1720.TW) has a market capitalization of approximately $11.22 billion, as of August 26, 2026, based on the most recent share price and shares outstanding.
Does 1720.TW pay a dividend?: Yes — Standard Chem & Pharm Co. Ltd. (1720.TW) pays a dividend annually, with a trailing-twelve-month yield of 3.50%. Full distribution history, payout ratios, and growth rates are on the Dividend tab.